Selected Publications
2017
Hu Y, Semova I, Sun X, Kang H, Chahar S, Hollenberg AN, Masson D, Hirschey MD,
Miao J, Biddinger SB. Fructose and glucose regulate mammalian target of rapamycin
complex 1 and can activate lipogenic gene expression via distinct pathways. J
Biol Chem. 2017 Dec 8.
Hu Y, Shin DJ, Pan H, Lin Z, Dreyfuss JM, Camargo FD, Miao J, Biddinger SB.
YAP suppresses gluconeogenic gene expression through PGC1α. Hepatology. 2017
Dec;66(6):2029-2041. doi: 10.1002/hep.29373. Epub 2017 Oct 30. PubMed PMID:
28714135.
Key CC, Liu M, Kurtz CL, Chung S, Boudyguina E, Dinh TA, Bashore A, Phelan PE,
Freedman BI, Osborne TF, Zhu X, Ma L, Sethupathy P, Biddinger SB, Parks JS.
Hepatocyte ABCA1 Deletion Impairs Liver Insulin Signaling and Lipogenesis. Cell
Rep. 2017 Jun 6;19(10):2116-2129.
Levenson AE, Wadwa RP, Shah AS, Khoury PR, Kimball TR, Urbina EM, de Ferranti
SD, Bishop FK, Maahs DM, Dolan LM, Biddinger SB. PCSK9 Is Increased in Youth With
Type 1 Diabetes. Diabetes Care. 2017 Jul;40(7):e85-e87. doi: 10.2337/dc16-2563.
Epub 2017 Jun 6.
Levenson AE, Shah AS, Khoury PR, Kimball TR, Urbina EM, de Ferranti SD, Maahs
DM, Dolan LM, Wadwa RP, Biddinger SB. Obesity and type 2 diabetes are associated
with elevated PCSK9 levels in young women. Pediatr Diabetes. 2017
2016
Haas ME, Levenson AE, Sun X, Liao WH, Rutkowski JM, de Ferranti SD, Schumacher
VA, Scherer PE, Salant DJ, Biddinger SB. The Role of Proprotein Convertase
Subtilisin/Kexin Type 9 in Nephrotic Syndrome-Associated Hypercholesterolemia.
Circulation. 2016 Jul 5;134(1):61-72.
Levenson AE, Haas ME, Miao J, Brown RJ, de Ferranti SD, Muniyappa R, Biddinger
SB. Effect of Leptin Replacement on PCSK9 in ob/ob Mice and Female Lipodystrophic
Patients. Endocrinology. 2016 Jan 29.
Sun X, Haas ME, Miao J, Mehta A, Graham MJ, Crooke RM, de Barros JP, Wang JG,
Aikawa M, Masson D, Biddinger SB. Insulin Dissociates the Effects of Liver X
Receptor on Lipogenesis, Endoplasmic Reticulum Stress, and Inflammation. J Biol
Chem. 2016 Jan 15;291(3):1115-22.
2015
Miao J, Manthena PV, Haas ME, Ling AV, Shin DJ, Graham MJ, Crooke RM, Liu J,
Biddinger SB. Role of Insulin in the Regulation of Proprotein Convertase
Subtilisin/Kexin Type 9. Arterioscler Thromb Vasc Biol. 2015 Jul;35(7):1589-96.
Miao J, Ling AV, Manthena PV, Gearing ME, Graham MJ, Crooke RM, Croce KJ,
Esquejo RM, Clish CB; Morbid Obesity Study Group, Vicent D, Biddinger SB.
Flavin-containing monooxygenase 3 as a potential player in diabetes-associated
atherosclerosis. Nat Commun. 2015 Apr 7;6:6498.
2014
Miao J, Haas JT, Manthena P, Wang Y, Zhao E, Vaitheesvaran B, Kurland IJ,
Biddinger SB. Hepatic insulin receptor deficiency impairs the SREBP-2 response to
feeding and statins. J Lipid Res. 2014 Apr;55(4):659-67.
David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV,
Devlin AS, Varma Y, Fischbach MA, Biddinger SB, Dutton RJ, Turnbaugh PJ. Diet
rapidly and reproducibly alters the human gut microbiome. Nature. 2014 Jan
23;505(7484):559-63.
Kurtz CL, Peck BC, Fannin EE, Beysen C, Miao J, Landstreet SR, Ding S, Turaga
V, Lund PK, Turner S, Biddinger SB, Vickers KC, Sethupathy P. microRNA-29
fine-tunes the expression of key FOXA2-activated lipid metabolism genes and is
dysregulated in animal models of insulin resistance and diabetes. Diabetes. 2014
Apr 10.
2013
Haas ME, Attie AD, Biddinger SB. The regulation of ApoB metabolism by insulin.
Trends Endocrinol Metab. 2013 Aug;24(8):391-7.
2012
Haas JT, Miao J, Chanda D, Wang Y, Zhao E, Haas ME, Hirschey M, Vaitheesvaran
B, Farese RV Jr, Kurland IJ, Graham M, Crooke R, Foufelle F, Biddinger SB.
Hepatic insulin signaling is required for obesity-dependent expression of
SREBP-1c mRNA but not for feeding-dependent expression. Cell Metab. 2012 Jun
6;15(6):873-84
2011
Olivier Bezy, Thien T. Tran, Jussi Pihlajamäki, Ryo Suzuki, Brice Emanuelli, Jonathan Winnay, Marcelo A. Mori, Joel Haas, Sudha B. Biddinger, Michael Leitges, Allison B. Goldfine, Mary Elizabeth Patti, George L. King and C. Ronald Kahn. PKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans. J Clin Invest. 2011.
Zhou Y, Lee J, Reno CM, Sun C, Park SW, Chung J, Lee J, Fisher SJ, White MF, Biddinger SB, Ozcan U. Regulation of glucose homeostasis through a XBP-1-FoxO1 interaction. Nat Med. 2011;17(3):356-65.
2010
Suzuki R, Lee K, Jing E, Biddinger SB, McDonald JG, Montine TJ, Craft S, Kahn CR. Diabetes and insulin in regulation of brain cholesterol metabolism. Cell Metab. 2010;12(6):567-79.
Hirschey MD, Shimazu T, Goetzman E, Jing E, Schwer B, Lombard DB, Grueter CA, Harris C, Biddinger S, Ilkayeva OR, Stevens RD, Li Y, Saha AK, Ruderman NB, Bain JR, Newgard CB, Farese RV, Alt FW, Kahn CR, Verdin E. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature. 2010;464(7285):121-5.
2009
Haas JT, Biddinger SB. Dissecting the role of insulin resistance in the metabolic syndrome. Curr Opin Lipidol. 2009;20(3):206-10.
2008
Scapa EF, Pocai A, Wu MK, Gutierrez-Juarez R, Glenz L, Kanno K, Li H, Biddinger S, Jelicks LA, Rossetti L, Cohen DE. Regulation of energy substrate utilization and hepatic insulin sensitivity by phosphatidylcholine transfer protein/StarD2. FASEB J. 2008.
Biddinger SB, Haas JT, Yu BB, Bezy O, Jing E, Zhang W, Unterman TG, Carey MC, Kahn CR. Hepatic insulin resistance directly promotes formation of cholesterol gallstones. Nat Med. 2008;14(7):778-82.
Biddinger SB, Hernandez-Ono A, Rask-Madsen C, Haas JT, Alemán JO, Suzuki R, Scapa EF, Agarwal C, Carey MC, Stephanopoulos G, Cohen DE, King GL, Ginsberg HN, Kahn CR. Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab. 2008;7(2):125-34.
Hu Y, Semova I, Sun X, Kang H, Chahar S, Hollenberg AN, Masson D, Hirschey MD,
Miao J, Biddinger SB. Fructose and glucose regulate mammalian target of rapamycin
complex 1 and can activate lipogenic gene expression via distinct pathways. J
Biol Chem. 2017 Dec 8.
Hu Y, Shin DJ, Pan H, Lin Z, Dreyfuss JM, Camargo FD, Miao J, Biddinger SB.
YAP suppresses gluconeogenic gene expression through PGC1α. Hepatology. 2017
Dec;66(6):2029-2041. doi: 10.1002/hep.29373. Epub 2017 Oct 30. PubMed PMID:
28714135.
Key CC, Liu M, Kurtz CL, Chung S, Boudyguina E, Dinh TA, Bashore A, Phelan PE,
Freedman BI, Osborne TF, Zhu X, Ma L, Sethupathy P, Biddinger SB, Parks JS.
Hepatocyte ABCA1 Deletion Impairs Liver Insulin Signaling and Lipogenesis. Cell
Rep. 2017 Jun 6;19(10):2116-2129.
Levenson AE, Wadwa RP, Shah AS, Khoury PR, Kimball TR, Urbina EM, de Ferranti
SD, Bishop FK, Maahs DM, Dolan LM, Biddinger SB. PCSK9 Is Increased in Youth With
Type 1 Diabetes. Diabetes Care. 2017 Jul;40(7):e85-e87. doi: 10.2337/dc16-2563.
Epub 2017 Jun 6.
Levenson AE, Shah AS, Khoury PR, Kimball TR, Urbina EM, de Ferranti SD, Maahs
DM, Dolan LM, Wadwa RP, Biddinger SB. Obesity and type 2 diabetes are associated
with elevated PCSK9 levels in young women. Pediatr Diabetes. 2017
2016
Haas ME, Levenson AE, Sun X, Liao WH, Rutkowski JM, de Ferranti SD, Schumacher
VA, Scherer PE, Salant DJ, Biddinger SB. The Role of Proprotein Convertase
Subtilisin/Kexin Type 9 in Nephrotic Syndrome-Associated Hypercholesterolemia.
Circulation. 2016 Jul 5;134(1):61-72.
Levenson AE, Haas ME, Miao J, Brown RJ, de Ferranti SD, Muniyappa R, Biddinger
SB. Effect of Leptin Replacement on PCSK9 in ob/ob Mice and Female Lipodystrophic
Patients. Endocrinology. 2016 Jan 29.
Sun X, Haas ME, Miao J, Mehta A, Graham MJ, Crooke RM, de Barros JP, Wang JG,
Aikawa M, Masson D, Biddinger SB. Insulin Dissociates the Effects of Liver X
Receptor on Lipogenesis, Endoplasmic Reticulum Stress, and Inflammation. J Biol
Chem. 2016 Jan 15;291(3):1115-22.
2015
Miao J, Manthena PV, Haas ME, Ling AV, Shin DJ, Graham MJ, Crooke RM, Liu J,
Biddinger SB. Role of Insulin in the Regulation of Proprotein Convertase
Subtilisin/Kexin Type 9. Arterioscler Thromb Vasc Biol. 2015 Jul;35(7):1589-96.
Miao J, Ling AV, Manthena PV, Gearing ME, Graham MJ, Crooke RM, Croce KJ,
Esquejo RM, Clish CB; Morbid Obesity Study Group, Vicent D, Biddinger SB.
Flavin-containing monooxygenase 3 as a potential player in diabetes-associated
atherosclerosis. Nat Commun. 2015 Apr 7;6:6498.
2014
Miao J, Haas JT, Manthena P, Wang Y, Zhao E, Vaitheesvaran B, Kurland IJ,
Biddinger SB. Hepatic insulin receptor deficiency impairs the SREBP-2 response to
feeding and statins. J Lipid Res. 2014 Apr;55(4):659-67.
David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV,
Devlin AS, Varma Y, Fischbach MA, Biddinger SB, Dutton RJ, Turnbaugh PJ. Diet
rapidly and reproducibly alters the human gut microbiome. Nature. 2014 Jan
23;505(7484):559-63.
Kurtz CL, Peck BC, Fannin EE, Beysen C, Miao J, Landstreet SR, Ding S, Turaga
V, Lund PK, Turner S, Biddinger SB, Vickers KC, Sethupathy P. microRNA-29
fine-tunes the expression of key FOXA2-activated lipid metabolism genes and is
dysregulated in animal models of insulin resistance and diabetes. Diabetes. 2014
Apr 10.
2013
Haas ME, Attie AD, Biddinger SB. The regulation of ApoB metabolism by insulin.
Trends Endocrinol Metab. 2013 Aug;24(8):391-7.
2012
Haas JT, Miao J, Chanda D, Wang Y, Zhao E, Haas ME, Hirschey M, Vaitheesvaran
B, Farese RV Jr, Kurland IJ, Graham M, Crooke R, Foufelle F, Biddinger SB.
Hepatic insulin signaling is required for obesity-dependent expression of
SREBP-1c mRNA but not for feeding-dependent expression. Cell Metab. 2012 Jun
6;15(6):873-84
2011
Olivier Bezy, Thien T. Tran, Jussi Pihlajamäki, Ryo Suzuki, Brice Emanuelli, Jonathan Winnay, Marcelo A. Mori, Joel Haas, Sudha B. Biddinger, Michael Leitges, Allison B. Goldfine, Mary Elizabeth Patti, George L. King and C. Ronald Kahn. PKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans. J Clin Invest. 2011.
Zhou Y, Lee J, Reno CM, Sun C, Park SW, Chung J, Lee J, Fisher SJ, White MF, Biddinger SB, Ozcan U. Regulation of glucose homeostasis through a XBP-1-FoxO1 interaction. Nat Med. 2011;17(3):356-65.
2010
Suzuki R, Lee K, Jing E, Biddinger SB, McDonald JG, Montine TJ, Craft S, Kahn CR. Diabetes and insulin in regulation of brain cholesterol metabolism. Cell Metab. 2010;12(6):567-79.
Hirschey MD, Shimazu T, Goetzman E, Jing E, Schwer B, Lombard DB, Grueter CA, Harris C, Biddinger S, Ilkayeva OR, Stevens RD, Li Y, Saha AK, Ruderman NB, Bain JR, Newgard CB, Farese RV, Alt FW, Kahn CR, Verdin E. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature. 2010;464(7285):121-5.
2009
Haas JT, Biddinger SB. Dissecting the role of insulin resistance in the metabolic syndrome. Curr Opin Lipidol. 2009;20(3):206-10.
2008
Scapa EF, Pocai A, Wu MK, Gutierrez-Juarez R, Glenz L, Kanno K, Li H, Biddinger S, Jelicks LA, Rossetti L, Cohen DE. Regulation of energy substrate utilization and hepatic insulin sensitivity by phosphatidylcholine transfer protein/StarD2. FASEB J. 2008.
Biddinger SB, Haas JT, Yu BB, Bezy O, Jing E, Zhang W, Unterman TG, Carey MC, Kahn CR. Hepatic insulin resistance directly promotes formation of cholesterol gallstones. Nat Med. 2008;14(7):778-82.
Biddinger SB, Hernandez-Ono A, Rask-Madsen C, Haas JT, Alemán JO, Suzuki R, Scapa EF, Agarwal C, Carey MC, Stephanopoulos G, Cohen DE, King GL, Ginsberg HN, Kahn CR. Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab. 2008;7(2):125-34.
|
Sudha Biddinger, MD/PhD
Harvard Medical School Children's Hospital Boston |
